BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 27394391)

  • 1. Axillary node metastatic carcinoma without definitive primary: a case report.
    Anderson SR; Scarborough CS
    Int J Surg Case Rep; 2016; 25():196-8. PubMed ID: 27394391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Elusive Primary: Metastatic Adenocarcinoma of the Breast Presenting Solely as a Hard Sternal Mass.
    Mohd Omar R; Ismail IA; Md Yasin M; Ahmad Affandi K; Hasbullah HH; Mohamad Ali ND
    Am J Case Rep; 2023 Aug; 24():e940594. PubMed ID: 37608536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic and therapeutic management of cancer of an unknown primary.
    Pavlidis N; Briasoulis E; Hainsworth J; Greco FA
    Eur J Cancer; 2003 Sep; 39(14):1990-2005. PubMed ID: 12957453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occult breast carcinoma presenting as an axillary mass.
    Scoggins CR; Vitola JV; Sandler MP; Atkinson JB; Frexes-Steed M
    Am Surg; 1999 Jan; 65(1):1-5. PubMed ID: 9915521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Site-specific cancer deaths in cancer of unknown primary diagnosed with lymph node metastasis may reveal hidden primaries.
    Hemminki K; Bevier M; Sundquist J; Hemminki A
    Int J Cancer; 2013 Feb; 132(4):944-50. PubMed ID: 22730111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current and Emerging Therapies for HER2-Positive Women With Metastatic Breast Cancer.
    Porter K; Rosenzweig MQ
    J Adv Pract Oncol; 2017 Mar; 8(2):164-168. PubMed ID: 29900024
    [No Abstract]   [Full Text] [Related]  

  • 7. Folliculotropic Cutaneous Metastases and Lymphangitis Carcinomatosa: When Cutaneous Metastases of Breast Carcinoma Are Mistaken for Cutaneous Infections.
    Paolino G; Panetta C; Didona D; Donati M; Donati P
    Acta Dermatovenerol Croat; 2016 Jun; 24(2):154-7. PubMed ID: 27477179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metastases from Occult Breast Cancer: A Case Report of Carcinoma of Unknown Primary Syndrome.
    Barbieri E; Anghelone CAP; Gentile D; La Raja C; Bottini A; Tinterri C
    Case Rep Oncol; 2020; 13(3):1158-1163. PubMed ID: 33173479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [CUP syndrome: are there advances?].
    Moll R
    Verh Dtsch Ges Pathol; 2005; 89():125-36. PubMed ID: 18035682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carcinoma of unknown primary (CUP); some considerations about pathogenesis and diagnostic strategy, particularly focusing on CUPS pertaining to the Urology.
    Alberti C
    G Chir; 2012; 33(1-2):41-6. PubMed ID: 22357439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carcinoma of Unknown Primary Site (CUP) With Metastatic Renal-Cell Carcinoma (mRCC) Histologic and Immunohistochemical Characteristics (CUP-mRCC): Results From Consecutive Patients Treated With Targeted Therapy and Review of Literature.
    Overby A; Duval L; Ladekarl M; Laursen BE; Donskov F
    Clin Genitourin Cancer; 2019 Feb; 17(1):e32-e37. PubMed ID: 30268423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic impact of presumed breast or ovarian cancer among patients with unfavorable-subset cancer of unknown primary site.
    Kodaira M; Yonemori K; Shimoi T; Yoshida A; Yoshida M; Kitano A; Shimomura A; Yunokawa M; Shimizu C; Takiguchi Y; Fujiwara Y; Tamura K
    BMC Cancer; 2018 Feb; 18(1):176. PubMed ID: 29433539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer of Unknown Primary: A Review on Clinical Guidelines in the Development and Targeted Management of Patients with the Unknown Primary Site.
    Qaseem A; Usman N; Jayaraj JS; Janapala RN; Kashif T
    Cureus; 2019 Sep; 11(9):e5552. PubMed ID: 31695975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and management of metastatic neoplasms with unknown primary.
    Bochtler T; Löffler H; Krämer A
    Semin Diagn Pathol; 2018 May; 35(3):199-206. PubMed ID: 29203116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian carcinoma initially presenting as metastatic axillary lymphadenopathy.
    Hockstein S; Keh P; Lurain JR; Fishman DA
    Gynecol Oncol; 1997 Jun; 65(3):543-7. PubMed ID: 9190992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Axillary nodal metastasis of occult breast primary cancer.
    Tamiolakis D; Antoniou C
    Chirurgia (Bucur); 2008; 103(4):467-71. PubMed ID: 18780622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary epithelioid trophoblastic tumor with a synchronous breast carcinoma detected only with FDG-PET/CT Scan.
    Kara T; Ozcan Kara P; Baba F; Celik C; Kara Gedik G
    Rev Esp Med Nucl; 2011; 30(6):368-71. PubMed ID: 21440960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of occult breast carcinoma with irradiation therapy and axillary lymph node dissection].
    Sugiyama Y; Morifuji M; Tatsumoto N; Sasaki M; Naito H; Kai Y
    Gan To Kagaku Ryoho; 2006 Sep; 33(9):1287-9. PubMed ID: 16969026
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Thapa P; Kalshetty A; Basu S
    World J Nucl Med; 2018; 17(4):219-222. PubMed ID: 30505217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.